{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:50Z","timestamp":1791928910245,"version":"4.3.4"},"reference-count":52,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,1,15]]},"DOI":"10.1167\/iovs.66.1.39","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T11:31:20Z","timestamp":1736940680000},"page":"39","source":"Crossref","is-referenced-by-count":2,"title":["Novel Anti-Microbial\/Anti-Inflammatory Combination Improves Clinical Outcome of\n                    <i>Bacillus cereus<\/i>\n                    Endophthalmitis"],"prefix":"10.1167","volume":"66","author":[{"given":"Md Huzzatul","family":"Mursalin","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma City, Oklahoma, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip S.","family":"Coburn","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma City, Oklahoma, United States"},{"name":"Dean McGee Eye Institute, Oklahoma City, Oklahoma, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Longoria-Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Astley","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma City, Oklahoma, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.","family":"Fischetti","sequence":"additional","affiliation":[{"name":"Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Callegan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma City, Oklahoma, United States"},{"name":"Dean McGee Eye Institute, Oklahoma City, Oklahoma, United States"},{"name":"Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"104206","DOI":"10.1016\/j.micpath.2020.104206","article-title":"Ocular bacterial infections: pathogenesis and diagnosis","volume":"145","author":"Deepthi","year":"2020","journal-title":"Microb Pathog"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12886-017-0612-2","article-title":"Bacterial profile of ocular infections: a systematic review","volume":"17","author":"Teweldemedhin","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.15.1.111-124.2002","article-title":"Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions","volume":"15","author":"Callegan","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.preteyeres.2006.12.001","article-title":"Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions","volume":"26","author":"Callegan","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1128\/IAI.67.7.3348-3356.1999","article-title":"Pathogenesis of gram-positive bacterial endophthalmitis","volume":"67","author":"Callegan","year":"1999","journal-title":"Infect Immun"},{"issue":"11","key":"bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/toxins11060356","article-title":"An eye on Staphylococcus aureus toxins: roles in ocular damage and inflammation","volume":"19","author":"Astley","year":"2019","journal-title":"Toxins (Basel)"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"001057","DOI":"10.1099\/mic.0.001057","article-title":"The Bacillus virulome in endophthalmitis","volume":"167","author":"Coburn","year":"2021","journal-title":"Microbiology (Reading)"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/microorganisms7110537","article-title":"A pyrrhic victory: the PMN response to ocular bacterial infections","volume":"7","author":"Livingston","year":"2019","journal-title":"Microorganisms"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"107959","DOI":"10.1016\/j.exer.2020.107959","article-title":"The cereus matter of Bacillus endophthalmitis","volume":"193","author":"Mursalin","year":"2020","journal-title":"Exp Eye Res"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/02713680600976925","article-title":"Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis","volume":"31","author":"Ramadan","year":"2006","journal-title":"Curr Eye Res"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0039-6257(97)00005-2","article-title":"Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy","volume":"41","author":"Roth","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.4103\/ijo.IJO_512_17","article-title":"Role of intravitreal\/Intracameral antibiotics to prevent traumatic endophthalmitis - meta-analysis","volume":"65","author":"Thevi","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jgar.2022.03.010","article-title":"Antibiotic susceptibility of bacterial pathogens isolated from the aqueous and vitreous humour in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) Surveillance Study: 2009\u20132020 update","volume":"29","author":"Asbell","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40123-021-00449-9","article-title":"A systematic review of multi-decade antibiotic resistance data for ocular bacterial pathogens in the United States","volume":"11","author":"Bispo","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.4103\/ijo.IJO_955_21","article-title":"Visual outcomes of acute bacterial endophthalmitis treated with adjuvant intravitreal dexamethasone: a meta-analysis and systematic review","volume":"70","author":"Soekamto","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12886-020-01449-2","article-title":"Long-term visual outcomes of endophthalmitis and the role of systemic steroids in addition to intravitreal dexamethasone","volume":"20","author":"Conrady","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/09273948.2016.1245758","article-title":"A review of the role of intravitreal corticosteroids as an adjuvant to antibiotics in infectious endophthalmitis","volume":"26","author":"Ching Wen","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12223-016-0471-x","article-title":"Bacteriophages and its applications: an overview","volume":"62","author":"Sharma","year":"2017","journal-title":"Folia Microbiol. (Praha)"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/v11060567","article-title":"Understanding and exploiting Phage-host interactions","volume":"11","author":"Stone","year":"2019","journal-title":"Viruses"},{"key":"bib21","first-page":"135","article-title":"The language of phages","volume":"15","author":"Du Toit","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/B978-0-12-394438-2.00006-2","article-title":"Bacteriophage protein-protein interactions","volume":"83","author":"H\u00e4user","year":"2012","journal-title":"Adv Virus Res"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.mib.2008.09.012","article-title":"Bacteriophage lysins as effective antibacterials","volume":"11","author":"Fischetti","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.3389\/fimmu.2018.02252","article-title":"Phage lysins for fighting bacterial respiratory infections: a new generation of antimicrobials","volume":"9","author":"V\u00e1zquez","year":"2018","journal-title":"Front Immunol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tim.2005.08.007","article-title":"Bacteriophage lytic enzymes: novel anti-infectives","volume":"13","author":"Fischetti","year":"2005","journal-title":"Trends Microbiol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijmm.2010.04.002","article-title":"Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens","volume":"300","author":"Fischetti","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3389\/fphar.2019.00513","article-title":"Advantages and limitations of bacteriophages for the treatment of bacterial infections","volume":"10","author":"Principi","year":"2019","journal-title":"Front Pharmacol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1099\/jmm.0.061028-0","article-title":"Lysins: the arrival of pathogen-directed anti-Infectives","volume":"62","author":"Pastagia","year":"2013","journal-title":"J Med Microbiol"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1749-6632.2003.tb06050.x","article-title":"Novel method to control pathogenic bacteria on human mucous membranes","volume":"987","author":"Fischetti","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial resistance: implications and costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect Drug Resist"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"key":"bib32","first-page":"277","article-title":"The antibiotic resistance crisis: Part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P T"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.pop.2018.05.006","article-title":"Emergence of global antibiotic resistance","volume":"45","author":"Morehead","year":"2018","journal-title":"Prim Care"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00284-016-1166-x","article-title":"Phage therapy in bacterial infections treatment: one hundred years after the discovery of bacteriophages","volume":"74","author":"Cisek","year":"2017","journal-title":"Curr Microbiol"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","article-title":"Phage therapy for antibiotic-resistant bacterial infections","volume":"73","author":"Hatfull","year":"2022","journal-title":"Annu Rev Med"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nature01026","article-title":"A bacteriolytic agent that detects and kills Bacillus anthracis","volume":"418","author":"Schuch","year":"2002","journal-title":"Nature"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1186\/1472-6831-6-S1-S16","article-title":"Using phage lytic enzymes to control pathogenic bacteria","volume":"6","author":"Fischetti","year":"2006","journal-title":"BMC Oral Health"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"e47742","DOI":"10.1371\/journal.pone.0047742","article-title":"Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration","volume":"7","author":"Fukuda","year":"2012","journal-title":"PLoS One"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1128\/AAC.00126-14","article-title":"Intravitreal injection of the chimeric phage endolysin ply187 protects mice from Staphylococcus aureus endophthalmitis","volume":"58","author":"Singh","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"e0004423","DOI":"10.1128\/msphere.00044-23","article-title":"Therapeutic potential of Bacillus phage lysin PlyB in ocular infections","volume":"8","author":"Mursalin","year":"2023","journal-title":"mSphere"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jmb.2006.11.056","article-title":"The 1.6 a crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis","volume":"366","author":"Porter","year":"2007","journal-title":"J Mol Biol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"e00003","DOI":"10.1128\/AEM.00003-19","article-title":"The PlyB endolysin of bacteriophage vB_Bans_Bcp1 exhibits broad-spectrum bactericidal activity against Bacillus cereus sensu lato isolates","volume":"85","author":"Schuch","year":"2019","journal-title":"Appl Environ Microbiol"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"e28619","DOI":"10.1371\/journal.pone.0028619","article-title":"Role of Toll-like receptor (TLR) 2 in experimental Bacillus cereus endophthalmitis","volume":"6","author":"Novosad","year":"2011","journal-title":"PLoS One"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1128\/IAI.00502-15","article-title":"Unexpected roles for Toll-like receptor 4 and TRIF in intraocular infection with gram-positive bacteria","volume":"83","author":"Parkunan","year":"2015","journal-title":"Infect Immun"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.61.13.17","article-title":"Innate immune interference attenuates inflammation in Bacillus endophthalmitis","volume":"61","author":"Mursalin","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fimmu.2020.00215","article-title":"Bacillus S-layer-mediated innate interactions during endophthalmitis","volume":"11","author":"Mursalin","year":"2020","journal-title":"Front Immunol"},{"key":"bib47","article-title":"Intravitreal injection and quantitation of infection parameters in a mouse model of bacterial endophthalmitis [published online ahead of print February 6, 2021]","author":"Mursalin","journal-title":"J Vis Exp"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.mucimm.2023.04.005","article-title":"A2Ar-dependent PD-1+ and TIGIT+ Treg cells have distinct homing requirements to suppress autoimmune uveitis in mice","volume":"16","author":"Peters","year":"2023","journal-title":"Mucosal Immunol"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1167\/iovs.19-27453","article-title":"S-Layer impacts the virulence of Bacillus in endophthalmitis","volume":"60","author":"Mursalin","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/01.ATV.0000079340.80744.B8","article-title":"Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2","volume":"23","author":"Walton","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.4049\/jimmunol.0903594","article-title":"Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation","volume":"185","author":"Oskolkova","year":"2010","journal-title":"J Immunol"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/ars.2009.2597","article-title":"Generation and biological activities of oxidized phospholipids","volume":"12","author":"Bochkov","year":"2010","journal-title":"Antioxid Redox Signal"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2802473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:04Z","timestamp":1791927124000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2802473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,2]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.1.39","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,15]]}}}